- GlobeNewswire•8 days ago
ROCKVILLE, MD, Feb. 16, 2017-- MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of ...
- GlobeNewswire•15 days ago
ROCKVILLE, MD, Feb. 09, 2017-- MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of ...
- American City Business Journals•16 days ago
Three Washington-area execs added their names to a collection of 166 biotechnology executives and venture capitalists opposing President Donald Trump's so-called travel ban, saying the executive order will hinder innovation. In an open letter published this week in the journal Nature Biotechnology, the executives said the biotech industry has benefited from attracting top scientific talent from around the world.
MGNX : Summary for MacroGenics, Inc. - Yahoo Finance
MacroGenics, Inc. (MGNX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Ask||23.09 x 100|
|Day's Range||19.11 - 19.76|
|52 Week Range||14.90 - 33.30|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-12.98|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|